Press release
Fecal Microbiota Transplantation (FMT) Market Key Drivers, Size, Trends, Growth, Outlook 2024-2033
Fecal Microbiota Transplantation (FMT) Market Key Drivers
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=19430&type=smp
According to The Business Research Company's, The fecal microbiota transplantation (FMT) market size has grown strongly in recent years. It will grow from $0.80 billion in 2023 to $0.85 billion in 2024 at a compound annual growth rate (CAGR) of 6.7%. The growth in the historic period can be attributed to growing awareness of gut microbiome, expanding therapeutic applications, increasing personalized medicine, adoption in gastroenterology practices, increasing number of clinical trials and increasing funding and investments.
The fecal microbiota transplantation (FMT) market size is expected to see strong growth in the next few years. It will grow to $1.12 billion in 2028 at a compound annual growth rate (CAGR) of 7.0%. The growth in the forecast period can be attributed to increasing incidence of clostridium difficile infections (CDI), rising prevalence of inflammatory bowel diseases, increasing research and development activities, rising geriatric population, and expanding healthcare infrastructure. Major trends in the forecast period include the development of standardized protocols for donor screening, stool preparation, advances in microbiome analysis, improved stool processing technologies, novel delivery methods, and the development of synthetic or standardized microbiota-based products.
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/fecal-microbiota-transplantation-fmt-global-market-report
Market Drivers and Trends:
The rising prevalence of gastrointestinal disorders is expected to propel the growth of the fecal microbiota transplantation (FMT) market going forward. Gastrointestinal (GI) disorders refer to a wide range of conditions that affect the gastrointestinal tract, which includes the esophagus, stomach, small intestine, large intestine (colon), and anus. The rise in gastrointestinal disorders is due to increased stress, sedentary lifestyles, and higher consumption of processed foods. Fecal microbiota transplantation is used in gastrointestinal disorders to restore healthy gut bacteria, particularly for treating recurrent Clostridioides difficile infections. For instance, in 2023, according to Crohn's and Colitis Canada, a Canada-based non-profit organization, the number of people in Canada with IBD is increasing rapidly, from 322,600 in 2023 (0.8% of the population) to 470,000 in 2035 (1.1% of the population). In 2023, 11,000 people will be diagnosed (1 every 48 minutes), and by 2035, this will rise to 14,000 (1 every 38 minutes). Therefore, the rising prevalence of gastrointestinal disorders drives the growth of the fecal microbiota transplantation (FMT) market.
Major companies operating in the fecal microbiota transplantation (FMT) market are focusing on developing innovative solutions, such as microbiota-based live biotherapeutics, to enhance treatment efficacy for gastrointestinal disorders. Microbiota-based live biotherapeutics refer to live microorganisms used as therapeutic agents to restore or modify the gut microbiome for treating various diseases. For instance, in November 2022, Ferring Pharmaceuticals, a Switzerland-based biopharmaceutical company, received US Food and Drug Administration (FDA) approval for REBYOTA (fecal microbiota, live-jslm), a novel first-in-class microbiota-based live biotherapeutic indicated for the prevention of recurrence of Clostridioides difficile infection (CDI) in individuals 18 years of age and older, following antibiotic treatment for recurrent CDI. REBYOTA is indicated for preventing Clostridioides difficile (C. difficile) infection recurrence in individuals 18 years of age and older following antibiotic treatment for recurrent CDI.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Major Key Players of the Market:
Ferring Pharmaceuticals, Johns Hopkins Medicine, Seres Therapeutics, Taconic Biosciences, Enterome, Rebiotix Inc., Finch Therapeutics Group Inc., Locus Biosciences, Yeda Research and Development Co. Ltd., Microbiotica Limited, CosmosID Inc., AOBiome, Synthetic Biologics Inc., Osel Inc., OpenBiome, Asia Microbiota Bank, Taymount Clinic, MicroBiome Therapeutics LLC, MaaT Pharma SA, Kallyope
Fecal Microbiota Transplantation (FMT) Market 2024 Key Insights:
• The fecal microbiota transplantation (FMT) market size is expected to see strong growth in the next few years. It will grow to $1.12 billion in 2028 at a compound annual growth rate (CAGR) of 7.0%.
• Rising Prevalence Of Gastrointestinal Disorders Growth In Fecal Microbiota Transplantation (FMT) Market
• Innovative Advancements In Fecal Microbiota Transplantation Enhanced Market Growth
• North America was the largest region in the fecal microbiota transplantation (FMT) market in 2023
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/customise?id=19430&type=smp
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Fecal Microbiota Transplantation (FMT) Market Key Drivers, Size, Trends, Growth, Outlook 2024-2033 here
News-ID: 3760635 • Views: …
More Releases from The Business research company
In Vivo Contract Research Organization Market Insights Highlight Segment Expansi …
The in vivo contract research organization (CRO) sector is poised for significant expansion as the demand for efficient drug development and advanced research models grows. With increasing adoption of cutting-edge technologies and rising regulatory requirements, this market is set to experience substantial gains over the coming years. Let's explore the market's size, driving forces, key players, emerging trends, and segmentation insights to understand its evolving landscape.
Projected Market Value and Growth…
Implantable Cardioverter Defibrillators (ICDs) Market Report Evaluates Growth Dr …
The implantable cardioverter defibrillators (ICDs) market is poised for noteworthy expansion as advancements in medical technology and patient care continue to evolve. Increasing demand for improved cardiac monitoring and treatment options, combined with demographic shifts, is setting the stage for significant growth in this sector. Below is a detailed look at the anticipated market size, influential players, key trends, and segmentation within the ICDs market.
Projected Growth and Market Size of…
Immunoglobulin E (IgE) Allergy Blood Tests Market Report Provides Insights Into …
The immunoglobulin E (IgE) allergy blood tests market is positioned for significant expansion over the coming years, driven by advancements in diagnostic technology and rising awareness of allergies worldwide. This sector is evolving rapidly due to growing demand for accurate and efficient allergy detection methods, making it an important area for healthcare innovation and investment.
Market Growth Forecast and Size of the Immunoglobulin E (IgE) Allergy Blood Tests Market
The…
Image Guided And Robotic Assisted Procedures Market Analysis Highlights Growth T …
The field of image guided and robotic assisted procedures is on the brink of remarkable expansion, driven by technological progress and growing clinical adoption. Innovations in surgical robotics and imaging technologies are opening new avenues for precision surgery, promising enhanced patient outcomes and operational efficiency. Here is an overview of the market's current state, the key players shaping its future, emerging trends, and the market segments that are driving its…
More Releases for FMT
Fecal Microbiota Transplantation (FMT) Market Research Reveals Path To $1.27 Bil …
The fecal microbiota transplantation (FMT) market is positioned for significant advancement as growing scientific interest and technological improvements fuel its expansion. With increasing applications beyond traditional gastrointestinal treatments and ongoing innovations in delivery and manufacturing, this sector is on track for meaningful growth in the coming years. Below is an overview of the market's size, leading companies, emerging trends, and segment details.
Projected Market Size and Growth Outlook of the Fecal…
Fecal Microbiota Transplantation (FMT) Market Overview, Key Trends, and Major Pl …
The fecal microbiota transplantation (FMT) market is gaining significant traction as research around microbiome-based therapies advances and new applications emerge. With growing demand for standardized treatments and innovative delivery methods, this sector is set to experience substantial growth over the coming years. Here's a detailed overview of the market's valuation, key players, emerging trends, and segmentation.
Projected Market Value and Growth Outlook for Fecal Microbiota Transplantation (FMT)
The FMT market is…
Rising Prevalence Of Gastrointestinal Disorders Growth In Fecal Microbiota Trans …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Fecal Microbiota Transplantation (FMT) Market Size By 2025?
In recent times, there has been a substantial expansion in the size of the fecal microbiota transplantation (FMT) market. The market value is predicted to rise from $0.85 billion in 2024 to $0.91 billion in 2025, with…
Global and United States Fecal Microbiota Transplantation (FMT) Market to Witnes …
The Fecal Microbiota Transplantation(FMT) research report studies primary and secondary research in order to analyze the data effectively. The market study further also draws attention to crucial industry factors such as global clients, potential customers, and sellers, which instigates positive company growth. In order to gauge the turning point of the businesses, significant market key players are also enlisted in order to deliver readers with in-depth analysis about industry strategies.
The…
Aerobridge Market by Manufacturers: ADELTE, FMT, HÜBNER, JBT AeroTech, thyssenk …
Aerobridge Market research report aids accomplish the needs of businesses for which it analyses the market from top to bottom by considering plentiful parameters. A strong research methodology used here consists of data models that include market overview and guide, vendor positioning grid, market time line analysis, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. The Aerobridge Market report first…
Aerobridge Market to Witness Huge Growth by 2026 | ADELTE, FMT, HÜBNER, AeroTech
Global (United States, European Union and China) Aerobridge Market Research Report 2019-2025 is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global (United States, European Union and China) Aerobridge Market. Some of the key players…
